A new study suggests that a key group of transcription factors are 'druggable,' including several that could be targeted to treat cancer, metabolic disease, or autoimmune conditions.
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature